Literature DB >> 11744095

Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging.

M Vallée1, W Mayo, M Le Moal.   

Abstract

Aging is a general process of functional decline which involves in particular a decline of cognitive abilities. However, the severity of this decline differs from one subject to another and inter-individual differences have been reported in humans and animals. These differences are of great interest especially as concerns investigation of the neurobiological factors involved in cognitive aging. Intensive pharmacological studies suggest that neurosteroids, which are steroids synthesized in the brain in an independent manner from peripheral steroid sources, could be involved in learning and memory processes. This review summarizes data in animals and humans in favor of a role of neurosteroids in cognitive aging. Studies in animals demonstrated that the neurosteroids pregnenolone (PREG) and dehydroepiandrosterone (DHEA), as sulfate derivatives (PREGS and DHEAS, respectively), display memory-enhancing properties in aged rodents. Moreover, it was recently shown that memory performance was correlated with PREGS levels in the hippocampus of 24-month-old rats. Human studies, however, have reported contradictory results. First, improvement of learning and memory dysfunction was found after DHEA administration to individuals with low DHEAS levels, but other studies failed to detect significant cognitive effects after DHEA administration. Second, cognitive dysfunctions have been associated with low DHEAS levels, high DHEAS levels, or high DHEA levels; while in other studies, no relationship was found. As future research perspectives, we propose the use of new methods of quantification of neurosteroids as a useful tool for understanding their respective role in improving learning and memory impairments associated with normal aging and/or with pathological aging, such as Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744095     DOI: 10.1016/s0165-0173(01)00135-7

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  35 in total

1.  Changes in cytochrome P450 side chain cleavage expression in the rat hippocampus after kainate injury.

Authors:  Wan-Jie Chia; Andrew M Jenner; Akhlaq A Farooqui; Wei-Yi Ong
Journal:  Exp Brain Res       Date:  2007-11-27       Impact factor: 1.972

2.  Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged rats.

Authors:  Olivier George; Monique Vallée; Sergio Vitiello; Michel Le Moal; Pier-Vincenzo Piazza; Willy Mayo
Journal:  Biol Psychiatry       Date:  2010-05-14       Impact factor: 13.382

Review 3.  Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age-related changes.

Authors:  Olivier George; Monique Vallée; Michel Le Moal; Willy Mayo
Journal:  Psychopharmacology (Berl)       Date:  2006-01-17       Impact factor: 4.530

Review 4.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

5.  Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage.

Authors:  Jennifer C Naylor; Christine M Hulette; David C Steffens; Lawrence J Shampine; John F Ervin; Victoria M Payne; Mark W Massing; Jason D Kilts; Jennifer L Strauss; Patrick S Calhoun; Rohana P Calnaido; Daniel G Blazer; Jeffrey A Lieberman; Roger D Madison; Christine E Marx
Journal:  J Clin Endocrinol Metab       Date:  2008-05-13       Impact factor: 5.958

6.  Effect of SULT2B1 genetic polymorphisms on the sulfation of dehydroepiandrosterone and pregnenolone by SULT2B1b allozymes.

Authors:  Fatemah A Alherz; Amal A El Daibani; Maryam S Abunnaja; Ahsan F Bairam; Mohammed I Rasool; Yoichi Sakakibara; Masahito Suiko; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Mol Cell Endocrinol       Date:  2019-08-07       Impact factor: 4.102

7.  The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation.

Authors:  Subathra Murugan; Padmaja Jakka; Swapna Namani; Varadendra Mujumdar; Girish Radhakrishnan
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

Review 8.  Androgen therapy with dehydroepiandrosterone.

Authors:  Jacques Buvat
Journal:  World J Urol       Date:  2003-10-10       Impact factor: 4.226

Review 9.  Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials.

Authors:  Michael S Ritsner
Journal:  CNS Neurosci Ther       Date:  2010       Impact factor: 5.243

Review 10.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.